Oncorus Inc
Oncorus Inc
ONCR

Oncorus Inc (ONCR)

$1.295.15%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.26
Day's Range
$1.37
$0.9827
52-Week Range
$14.57
1 month return14.29%
3 month return22.29%
1 year return89.24%
5 year return91.5%

Company Information

At Oncorus, the company is focused on driving innovation to deliver next-generation viral immunotherapies to transform outcomes for cancer patients. Oncorus is advancing a portfolio of intratumorally and intravenously administered viral immunotherapies for multiple indications with significant unmet needs based on our oncolytic Herpes Simplex Virus (oHSV) Platform and Synthetic Virus Platform. Designed to deliver next-generation viral immunotherapy impact, our oHSV platform improves upon key characteristics of this therapeutic class to enhance potency without sacrificing safety, including greater capacity to encode transgenes to drive systemic immunostimulatory activity, retention of full replication competency to enable high tumor-killing potency, and orthogonal safety strategies to restrict viral activity to tumor cells. Its lead program, ONCR-177, is designed to be directly administered into a tumor, resulting in high local concentrations of the therapeutic agent, as well as low systemic exposure to the therapy, which we believe could potentially limit systemic toxicities.
OrganizationOncorus Inc
Employees56
CEO
IndustryHealth Technology

Analyst Recommendation

based on 10 analysts ratings

Buy
90%
Buy
10%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for Oncorus Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 3074.6%

Current

$1.26

Target

$40.0

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
30.8M
Book Value
5.03
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-2.56
Wall Street Target Price
17.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
0.27
Enterprise Value
-36909569
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.59

Technicals

50 Day MA
1.78
200 Day MA
6.6

Institutional Holdings

Deerfield Management Co

12.17%

Mpm Asset Management, LLC

11.01%

CHI Advisors LLC

9.34%

MPM Oncology Impact Management LP

9.18%

Citadel Advisors Llc

7.3%

BlackRock Inc

5.23%

Discover more

Frequently Asked Questions

What is Oncorus Inc share price today?

Can Indians buy Oncorus Inc shares?

How can I buy Oncorus Inc shares from India?

Can Fractional shares of Oncorus Inc be purchased?

What are the documents required to start investing in Oncorus Inc stocks?

What are today’s High and Low prices of Oncorus Inc?

What are today’s traded volumes of Oncorus Inc?

What is today’s market capitalisation of Oncorus Inc?

What is the 52 Week High and Low Range of Oncorus Inc?

How much percentage Oncorus Inc is down from its 52 Week High?

How much percentage Oncorus Inc is up from its 52 Week low?

What are the historical returns of Oncorus Inc?

Who is the Chief Executive Officer (CEO) of Oncorus Inc?